Poliscio Analytics LLC
  • Home
  • Latest FOIA Insights
  • FOIAengine
    • Log In
    • User Support
    • How to Use
    • About FOIA Engine
    • Trial User Signup
  • About
    • About PoliScio
    • Leadership
  • Newsroom
  • Contact
Select Page
A Raft of Document Requests from the FTC and Media

A Raft of Document Requests from the FTC and Media

by John A. Jenkins | Feb 7, 2024 | FOIA, FTC, Litigation

FOIAengine: Who’s Asking What, and Why? Days after the Federal Trade Commission launched an investigation of the five biggest players in artificial intelligence, Lina Khan was on a charm offensive aimed at winning the confidence of her biggest enemies on Wall...
“The Assassin” Strike Again

“The Assassin” Strike Again

by John A. Jenkins | Jan 31, 2024 | FDA, FOIA, SEC, Short-Selling, Stock Market

FOIAengine:  Short Seller Fahmi Quadir Goes for Another Kill To keep a nickname like “the Assassin,” the killer better not miss. By the time short seller Fahmi Quadir was scheduled to take the stage on January 30 at a big investment conference in Miami Beach, she had...
A Gambit to Allow Covid Vaccine Lawsuits

A Gambit to Allow Covid Vaccine Lawsuits

by Randy E. Miller | Jan 24, 2024 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals

In FOIAengine, a Law Firm’s Strategy Takes Shape When we tallied the hundreds of thousands of Freedom of Information Act requests filed with the federal government last year, one law firm stood out. According to PoliScio Analytics’ competitive-intelligence database...
A Raft of Document Requests from the FTC and Media

Busting Trusts, Breaking with Tradition

by John A. Jenkins | Jan 10, 2024 | Antitrust, FOIA, FTC, Law Firms, Litigation

Requests in FOIAengine Show Groups Watching the FTC When the Federal Trade Commission joined the Justice Department last month in announcing new merger guidelines, two years in the making, the revised rules of the road were a warning to acquisitive corporations: ...
Collateral Damage Follows A Medical Leap

Collateral Damage Follows A Medical Leap

by John A. Jenkins | Jan 3, 2024 | FDA, FOIA, Pharmaceuticals

FOIAengine Lines Up the  Players in a Huge Patent Fight When the Food and Drug Administration announced three weeks ago the approval of two milestone treatments for sickle cell disease, the agency hailed the action as “an innovative advancement in the field of gene...
Implant Manufacturer Targeted by Hedge Funds

Implant Manufacturer Targeted by Hedge Funds

by Randy E. Miller | Dec 13, 2023 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market

FOIAengine Reveals FOIA Requests About Establishment Labs Food and Drug Administration FOIA records released this month reveal that breast implant manufacturer Establishment Labs (NASDAQ: ESTA), previously targeted by well-known activist short-seller Hindenburg...
« Older Entries
Next Entries »
  • Terms of Service
  • Privacy Policy
Copyright 2025 PoliScio Analytics LLC